USP Leadership

Our Concerns Regarding Congressional Proposal to Discard Public Quality and Safety Standards for Biologics

Biologics Standards Proposal

For a hundred years, federal law has required that all drugs adhere to public quality standards—part of ensuring safety and protecting the public’s health. Language that would exempt biologics, including biosimilars, from adhering to the same public quality standards as other prescription medicines was recently added to the FDA and NIH Workforce Authorities Modernization Act. Learn about the potential impact this biologics quality exemption may have on competition, product development, and the public's confidence in biologics and biosimilars.

Share

Honoring the Volunteers Who Make USP’s Mission a Reality

USP Thanks Its Volunteers

In celebration of National Volunteer Week, USP is proud to recognize and honor the more than 640 volunteers who serve on USP’s standards-setting and advisory bodies—the USP Council of Expert, Expert Committees and Expert Panels. These dedicated individuals help USP fulfill its mission to improve global health by readily sharing their knowledge in the continuous revision of USP’s public standards that help ensure the quality of medicines, dietary supplements and foods.

Share

Celebrating the Global Impact of Quality: USP–India’s 10th Anniversary and Beyond

USP–India Celebrates Tenth Anniversary

Anthony Lakavage, Senior Vice President, USP Global External Affairs, shares insights on USP–India's 10th Anniversary and how USP is working globally to increase its impact on improving the quality of medicines, dietary supplements and foods worldwide.

Share

Pages